The AI in Business Podcast

• Leveraging AI for Better Outcomes Across Drug Development - with Patricio La Rosa of Bayer

  Today’s guest is Patricio La Rosa, Head of End-to-End Decision Science at Seed Production Innovation in Bayer Crop Science. With over 20 years of experience developing AI and data science solutions across healthcare and agriculture, Patricio joins Emerj Managing Editor Matthew DeMello to explore how machine learning can drive better outcomes across the drug development lifecycle, from research design to clinical deployment. Patricio discusses how AI is optimizing early trial planning, improving participant engagement, and supporting ethical, human-centered decisions at scale. Drawing lessons from both agriculture and life sciences, he emphasizes the importance of connecting technical models with real-world workflows. The conversation also delves into key barriers to AI adoption in clinical settings, including behavioral friction, model transparency, and challenges in orchestrating decision-making across global teams. Patricio offers a grounded perspective on what it takes to move from experimentation to enterprise impact in AI-driven R&D. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj’s flagship ‘AI in Business’ podcast!

  --------  

  33:16
• How Financial Services Are Building Safer Customer-Facing AI - with Akhil Khunger of Barclays

  Today’s guest is Akhil Khunger, VP in Quantitative Analytics at Barclays. Akhil returns to the program to discuss the evolving role of customer-facing AI in financial services and how financial institutions are embedding safety and security measures directly into client-facing systems. He delves into the risks financial services face, such as prompt injection and model jailbreaking, and how firms are balancing user experience with necessary guardrails. Later, he and Emerj Managing Editor Matthew DeMello explore the challenges of building transparent, trustworthy, and resilient AI systems for the next generation of financial services, especially in light of growing regulatory expectations. This episode is sponsored by ActiveFence. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj’s flagship ‘AI in Business’ podcast!

  --------  

  19:35
• The Future of Life Sciences AI with Full Integration and Human-Focused Collaboration - with Brice Challamel of Moderna

  Today’s guest is Brice Challamel, Head of AI products and Innovation at Moderna. With experience working across five continents, he brings a global perspective to driving AI adoption, innovation management, and measurable results in life sciences. Brice joins Emerj Managing Editor Matthew DeMello to explore how Moderna is embedding AI into both its tools and corporate culture to scale collaboration, accelerate product development, and improve regulatory outcomes. He breaks down how AI is augmenting human creativity, enhancing team decision-making, and supporting patient engagement efforts, while keeping human insight at the center of AI strategy. Brice also shares lessons from other industries to shed light on what’s ahead for AI in regulated sectors like life sciences, where the technology has the potential to improve operational efficiency, vaccine adoption, and broader public health outcomes. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj’s flagship ‘AI in Business’ podcast! This episode is sponsored by MSTRO. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

  --------  

  48:41
• Navigating Challenges and Solutions in Data Security with AI - with Dimitri Sirota of BigID

  As enterprises double down on generative AI initiatives, the intersection of data security, privacy, and unstructured data is quickly becoming mission-critical. In this episode, Dimitri Sirota, Co-founder and CEO of BigID, joins the podcast to explore how AI transformation is reshaping enterprise data governance, security, and compliance—and why understanding your “crown jewel” data is essential to building trustworthy AI systems. Dimitri outlines the three major forces driving today’s enterprise data challenges: accelerated cloud migration, a rising tide of global data privacy regulations, and the explosion of generative AI tools that rely on sensitive, unstructured data. He explains how enterprises can gain visibility into their AI programs and the data fueling them, mitigate shadow AI risks, and prepare for the next wave of agentic systems by adopting zero-trust models and real-time monitoring strategies. This episode is sponsored by BigID. Learn how BigID helps enterprises govern AI, mitigate data risk, and stay compliant here.

  --------  

  29:28
• Scaling AI for Clinical Trials - with Damion Nero of Takeda

  Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years of experience applying AI, machine learning, and real-world data to drug development and precision medicine, Damion joins Emerj Managing Editor Matthew DeMello to explore the evolving role of AI in drug development and supply chain management. He breaks down how AI is currently streamlining administrative and regulatory tasks, improving efficiency across clinical trials, and saving valuable time for healthcare professionals. Damion also discusses why broader, transformative supply chain efficiencies are still on the horizon, as AI continues to evolve and scale in the pharmaceutical industry. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj’s flagship ‘AI in Business’ podcast!

  --------  

  26:31

More Technology podcasts

Trending Technology podcasts

About The AI in Business Podcast

The AI in Business Podcast: Podcasts in Family